首页 > 市场调查报告书 > 製药

妇科治疗

市场调查报告书

商品编码

1547470

全球女性健康治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Women Health Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球女性健康治疗市场需求预计将从 2023 年的 882.8 亿美元达到近 1,506.8 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.12%。

用于诊断妊娠相关併发症、感染、子宫颈癌、卵巢癌和子宫癌等问题的治疗、疗法或药物被称为女性健康疗法。如今，女性不孕症病例不断增加，因此为延迟生育者提供生育服务越来越受到重视。而且，女性性功能障碍治疗的未满足需求导致了对女性健康治疗的需求。

市场动态

对女性健康及其治疗的认识不断提高是女性健康治疗市场成长的关键市场驱动力。为了满足与感染、癌症、怀孕等问题的治疗相关的未满足的药物需求而进行的高投资也是女性健康治疗市场成长的主要驱动力之一。与女性健康相关的慢性疾病预防的日益普及也被认为将引导女性健康治疗的市场成长。为女性提供更好健康的研发倡议的增加将进一步推动市场成长。此外，不良的营养摄取和生活方式的改变预计也会增加对治疗药物的需求，并刺激女性健康治疗药物的市场成长。然而，与治疗相关的高治疗成本以及与治疗方法的使用相关的副作用可能会限制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球女性健康治疗市场的每个细分市场进行了包容性评估。女性健康治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

女性健康治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按治疗类型

荷尔蒙治疗（雌激素治疗、黄体素治疗、合併治疗、甲状腺替代治疗、副甲状腺素治疗等）
非荷尔蒙治疗（标靶治疗药物、抗生素、双磷酸盐等）

按疾病适应症

癌症（乳癌、子宫颈癌、卵巢癌）
甲状腺功能低下症
停经后综合症
骨质疏鬆症
避孕
子宫肌瘤
泌尿道感染
其他的

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲女性健康治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。女性健康治疗市场的主要参与者包括礼来公司、诺华公司、辉瑞公司、默克公司、诺和诺德公司、安进公司、阿斯特捷利康、霍夫曼-拉罗氏有限公司、赛诺菲( Sanofi)、艾尔建(Allergan Plc)、葛兰素史克(GlaxoSmithKline Plc)、卢平製药(Lupin Pharmaceuticals Inc.) 本节包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：女性健康疗癒公司的竞争格局

女性健康治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Eli Lilly And Company

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Pfizer Inc.

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Novo Nordisk A/S

公司概况
公司收入
产品
最新动态

Amgen Inc.

公司概况
公司收入
产品
最新动态

AstraZeneca

公司概况
公司收入
产品
最新动态

F. Hoffmann-La Roche Ltd.

公司概况
公司收入
产品
最新动态

Sanofi

公司概况
公司收入
产品
最新动态

Allergan Plc

公司概况
公司收入
产品
最新动态

GlaxoSmithKline Plc

公司概况
公司收入
产品
最新动态

Lupin Pharmaceuticals Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215203

The global demand for Women Health Therapeutics Market is presumed to reach the market size of nearly USD 150.68 Billion by 2032 from USD 88.28 Billion in 2023 with a CAGR of 6.12% under the study period 2024-2032.

A treatment, therapy, or drug that is used for the diagnosis of issues like pregnancy-related complications, infection, cervical cancer, ovarian cancer, and uterine cancer, etc is known as women's health therapeutics. Nowadays, infertility cases in women are rising, so the focus on providing fertility services to those with delayed childbirth is increasing. And, the unmet needs of the treatment of female sexual dysfunction are leading to the demand for women's health therapeutics.

MARKET DYNAMICS

Rising awareness about women's health and its treatment is the key market driver for the growth of the women's health therapeutics market. High investments made to meet the unmet demands of drugs related to the treatment of issues like infections, cancer, pregnancy, etc is also one of the major driving force responsible for the market growth of women health therapeutics. The growing prevalence of prevention of chronic diseases related to women's health is also assumed to steer the market growth of women's health therapeutics. An increase in research and development initiatives for providing better health to women will further propel the market growth. Furthermore, bad nutritional intake and change in lifestyle are also expected to increase the demand for therapeutics and exhilarate the market growth of women's health therapeutics. However, the high treatment cost associated with the treatment and side effects associated with the usage of the therapeutics may restraint the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Women Health Therapeutics. The growth and trends of Women Health Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Women Health Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others)
Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others)

By Disease Indication

Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer)
Hypothyroidism
Post-menopausal Syndrome
Osteoporosis
Contraception
Uterine Fibroid
Urinary Tract Infection
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Women Health Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Women Health Therapeutics market include Eli Lilly And Company, Novartis AG, Pfizer Inc., Merck & Co. Inc., Novo Nordisk A/S, Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Sanofi, Allergan Plc, GlaxoSmithKline Plc, Lupin Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WOMEN HEALTH THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Disease Indication
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WOMEN HEALTH THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

5.1. Overview By Treatment Type
5.2. Historical and Forecast Data Analysis By Treatment Type
5.3. Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others) Historic and Forecast Sales By Regions
5.4. Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others) Historic and Forecast Sales By Regions

6. GLOBAL WOMEN HEALTH THERAPEUTICS MARKET ANALYSIS BY DISEASE INDICATION

6.1. Overview By Disease Indication
6.2. Historical and Forecast Data Analysis By Disease Indication
6.3. Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer) Historic and Forecast Sales By Regions
6.4. Hypothyroidism Historic and Forecast Sales By Regions
6.5. Post-menopausal Syndrome Historic and Forecast Sales By Regions
6.6. Osteoporosis Historic and Forecast Sales By Regions
6.7. Contraception Historic and Forecast Sales By Regions
6.8. Uterine Fibroid Historic and Forecast Sales By Regions
6.9. Urinary Tract Infection Historic and Forecast Sales By Regions
6.10. Others Historic and Forecast Sales By Regions

7. GLOBAL WOMEN HEALTH THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE WOMEN HEALTH THERAPEUTICS COMPANIES

8.1. Women Health Therapeutics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF WOMEN HEALTH THERAPEUTICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Eli Lilly And Company
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Novartis AG
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Pfizer Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Merck & Co. Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Novo Nordisk A/S
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Amgen Inc.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. AstraZeneca
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. F. Hoffmann-La Roche Ltd.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sanofi
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Allergan Plc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. GlaxoSmithKline Plc
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. Lupin Pharmaceuticals Inc
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Treatment Type (USD MN)
Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others) Market Sales By Geography (USD MN)
Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others) Market Sales By Geography (USD MN)
Analysis By Disease Indication (USD MN)
Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer) Market Sales By Geography (USD MN)
Hypothyroidism Market Sales By Geography (USD MN)
Post-menopausal Syndrome Market Sales By Geography (USD MN)
Osteoporosis Market Sales By Geography (USD MN)
Contraception Market Sales By Geography (USD MN)
Uterine Fibroid Market Sales By Geography (USD MN)
Urinary Tract Infection Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Women Health Therapeutics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Women Health Therapeutics Report
Market Research Process
Market Research Methodology
Global Women Health Therapeutics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Treatment Type
Market Attractiveness Analysis By Disease Indication
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Treatment Type (USD MN)
Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others) Market Sales By Geography (USD MN)
Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others) Market Sales By Geography (USD MN)
Global Market Analysis By Disease Indication (USD MN)
Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer) Market Sales By Geography (USD MN)
Hypothyroidism Market Sales By Geography (USD MN)
Post-menopausal Syndrome Market Sales By Geography (USD MN)
Osteoporosis Market Sales By Geography (USD MN)
Contraception Market Sales By Geography (USD MN)
Uterine Fibroid Market Sales By Geography (USD MN)
Urinary Tract Infection Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis